Abstract
The brain is the pacemaker of the human body. If this pacemaker does not function life is not possible. In the brain there are more than 10 billion neurons. Each neuron makes more than a thousand contacts. The axons of the neuron branches ramify into several end terminals which are in contact with other cell bodies and dendrites. The propagation of the impulse is electric in the axons and the dendrites; in the synaptic cleft, however, the impulse is propagated via a neurotransmitter. This highly effective chemical substance is released from the terminal and stimulates a postsynaptic receptor. The neurons, the axons, and the dendrites are embedded in lipid membranes and are therefore difficult to influence by chemical drugs. However, in the synaptic cleft the propagation of the nerve impulse is more open for manipulation. This is a part of the brain where chemical drugs can easily influence the brain function. Most of the psychotropic drugs used at present have effects at the synaptic level on the metabolism, on the release and the reuptake of neurotransmitters, and on the receptors.
This work was supported by grants from the Swedish Medical Research Council, the Lundbeck Foundation, the Fredrik and Ingrid Thuring Foundation, the Old Servant’s Foundation, the Greta and Johan Kock Foundation, the Hjalmar Svensson Foundation, and the Söderström-Königska Hospital Foundation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balldin J, Gottfries CG, Karlsson I, Lindstedt G, Längström G, Wilinder J (1983) Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 143: 277–281
Balldin J, Gottfries CG, Karlsson I, Lindstedt G, Lingström G, Svennerholm L (1988) Relationship between DST and the serotonergic system. Results from treatments with two 5-HT reuptake blockers in dementia disorders. Int J Geriatr Psychiatry 3: 17–26
Brine G, Gottfries CG, Karlsson I, Lekman A, Parnetti L, Svennerholm L (1989) Monoamine metabolites in CSF correlated to psychological variables in patients with dementia of Alzheimer type. Alzh Dem Ass Disord (to be published )
Carlsson A (1986) Neurotransmitters in old age and dementia. In: Heffner H, Moschel G, Sartorius N (eds) Mental health in the elderly: a review of the present state of research. Springer, Berlin Heidelberg New York, pp 154–161
Carlsson A, Winblad B (1976) Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38: 271–276
Drachmann DA, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 30: 113–121
Gottfries CG (1985) Review. Alzheimer’s disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252
Gottfries CG (1986) Nosological aspects of differential typology of dementia of Alzheimer type. In: Bergener M (ed) Dimensions in aging. Academic, London, pp 207–219
Gottfries CG, Brine G, Gullberg B, Steen G (1982) A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1: 311–330
Gottfries CG, Adolfsson R, Aquilonius SM, Carlsson A, Eckernäs SE, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type ( AD/SDAT ). Neurobiol Aging 4: 261–271
Gottfries CG, Bartfai T, Carlsson A, Eckernäs SA, Svennerholm L (1986) Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Prog Neuropsychopharmacol Biol Psychiatry 10: 405–413
Green AR (1985) Neuropharmacology of serotonin. Oxford University Press, Oxford
Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985) Review. Transmitter deficits in Alzheimer’s disease. Neurochem Int 7: 545–563
Jorm AF, Korten E, Henderson S (1987) Review article. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465–479
Marcusson JO, Alafuzoff I, Bäckström IT, Ericson E, Gottfries CG, Winblad B (1987) Hydroxytryptamine-sensitive (3H) imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders. Brain Res 425: 137–145
McEwen BS, Brinton RE (1987) Neuroendocrine aspects of adaptation. Prog Brain Res 72: 11–26
McGeer EG, Fibiger HC, McGeer PL, Wickson V (1971) Aging and brain enzymes. Exp Gerontol 6: 391–396
Nemeroff CB (1980) Neurotensin: perchance and endogenous neuroleptic? Biol Psychiatry 15: 283–302
Nemeroff CB, Lurringer D, Prange AJ (1983) Neurotensin and bombesin. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 16. Plenum, New York
Nordberg A, Nilsson L, Adern A, Winblad B (1988) Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. (Abstracts first international conference on Alzheimer disease and related disorders, Las Vegas, 6–9 Sept 1988). Alzh Dis Ass Disord 2: 212
Nyberg P, Nordberg A, Wester P, Winblad B (1983) Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson’s disease. Neurochem Pathol 1: 193–202
Nyth AL, Gottfries CG, Elgen K, Engedal K, Harenko A, Karlsson I, Koskinen T, Larsson L, Nygaard H, Samuelsson SM, Yli-Kerttula A (1988) The effect of citalopram in dementia disorders. A Scandinavian multi-center study. Poster at the CINP congress in Munich, Aug 15–19, 1988
Parnetti L, Gottfries J, Karlsson I, Lângström G, Gottfries CG, Svennerholm L (1987) Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high-performance liquid chromatography and gas-chromatography mass spectometry. Acta Psychiatr Scand 75: 542–548
Perry EK, Perry RH (1980) The cholinergic system in Alzheimer’s disease. In: Roberts RI (ed) Biochemistry of dementia. Wiley, Chichester, pp 135–183
Svanborg A, Landahl S, Mellström D (1983) Basic issues of health care. In: Thomas H, Maddox GL (eds) New perspectives on old age. A message to decision makers. Springer, Berlin Heidelberg New York, pp 31–52
Terenius L, Wahlström A, Lindström L, Widerlöv E (1976) Increased CSF levels of endorphines in chronic psychoses. Neurosci Lett 3: 157–162
Wallin A, Carlsson A, Ekman R, Gottfries CG, Karlsson I, Svennerholm L, Widerlöv E (1989) Hypothalamic biochemical disturbances in aging and in dementing disorders. To be published
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gottfries, C.G. (1989). Neurotransmitters in the Brain. In: Wolff, HP., Fleckenstein, A., Philipp, E.O. (eds) Drug Research and Drug Development in the 21st Century. Bayer AG Centenary Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74615-4_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-74615-4_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50961-5
Online ISBN: 978-3-642-74615-4
eBook Packages: Springer Book Archive